Microcephalic osteodysplastic primordial dwarfism type II


Microcephalic osteodysplastic primordial dwarfism type II is a form of primordial dwarfism associated with brain and skeletal abnormalities. It was characterized in 1982.
MOPD II is listed as a rare disease by the Office of Rare Diseases of the National Institutes of Health. This indicates that MOPD affects less than 200,000 people in the US population.
It is associated with the protein pericentrin.
Intelligence is reported by usually within low-normal or mild intellectual disability range. Some have average levels of intelligence, but may masked by specific learning disability.

Notable persons with MOPD II